The Bioprocess Validation Market in the United States is expanding as pharmaceutical, biotechnology, and biopharmaceutical companies increasingly prioritize manufacturing consistency, product quality, patient safety, and regulatory compliance. Market Overview The Bioprocess Validation Market size is expected to reach US$ 1.09 billion by 2031. The market is anticipated to register a CAGR of...